Dataset Information

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

ABSTRACT: BACKGROUND:Congenital heart disease (CHD) is the most prevalent congenital malformation affecting 1 in 100 newborns. While advances in early diagnosis and postnatal management have increased survival in CHD children, worrying long-term outcomes, particularly neurodevelopmental disability, have emerged as a key prognostic factor in the counseling of these pregnancies. METHODS:Eligible participants are women presenting at 20 to

SUBMITTER: Ribera I

PROVIDER: S-EPMC6737686 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Ribera I I Ruiz A A Sánchez O O Eixarch E E Antolín E E Gómez-Montes E E Pérez-Cruz M M Cruz-Lemini M M Sanz-Cortés M M Arévalo S S Ferrer Q Q Vázquez E E Vega L L Dolader P P Montoliu A A Boix H H Simões R V RV Masoller N N Sánchez-de-Toledo J J Comas M M Bartha J M JM Galindo A A Martínez J M JM Gómez-Roig L L Crispi F F Gómez O O Carreras E E Cabero L L Gratacós E E Llurba E E

BMC pediatrics 20190910 1

<h4>Background</h4>Congenital heart disease (CHD) is the most prevalent congenital malformation affecting 1 in 100 newborns. While advances in early diagnosis and postnatal management have increased survival in CHD children, worrying long-term outcomes, particularly neurodevelopmental disability, have emerged as a key prognostic factor in the counseling of these pregnancies.<h4>Methods</h4>Eligible participants are women presenting at 20 to < 37 weeks of gestation carrying a fetus with CHD. Mate ...[more]

PMID: 31506079

Similar Datasets

Project description:OBJECTIVES:To assess neurodevelopmental outcomes among participants with biliary atresia with their native liver at ages 12 months (group 1) and 24 months (group 2), and to evaluate variables predictive of neurodevelopmental impairment. STUDY DESIGN:Participants enrolled in a prospective, longitudinal, multicenter study underwent neurodevelopmental testing with either the Bayley Scales of Infant Development, 2nd edition, or Bayley Scales of Infant and Toddler Development, 3rd edition. Scores (normative mean?=?100?±?15) were categorized as ?100, 85-99, and <85 for ?2 analysis. Risk for neurodevelopmental impairment (defined as ?1 score of <85 on the Bayley Scales of Infant Development, 2nd edition, or Bayley Scales of Infant and Toddler Development, 3rd edition, scales) was analyzed using logistic regression. RESULTS:There were 148 children who completed 217 Bayley Scales of Infant and Toddler Development, 3rd edition, examinations (group 1, n?=?132; group 2, n?=?85). Neurodevelopmental score distributions significantly shifted downward compared with test norms at 1 and 2 years of age. Multivariate analysis identified ascites (OR,?3.17; P?=?.01) and low length z-scores at time of testing (OR,?0.70; P?<?.04) as risk factors for physical/motor impairment; low weight z-score (OR,?0.57; P?=?.001) and ascites (OR,?2.89; P?=?.01) for mental/cognitive/language impairment at 1 year of age. An unsuccessful hepatoportoenterostomy was predictive of both physical/motor (OR,?4.88; P?<?.02) and mental/cognitive/language impairment (OR,?4.76; P?=?.02) at 2 years of age. CONCLUSION:Participants with biliary atresia surviving with native livers after hepatoportoenterostomy are at increased risk for neurodevelopmental delays at 12 and 24 months of age. Those with unsuccessful hepatoportoenterostomy are >4 times more likely to have neurodevelopmental impairment compared with those with successful hepatoportoenterostomy. Growth delays and/or complications indicating advanced liver disease should alert clinicians to the risk for neurodevelopmental delays, and expedite appropriate interventions. TRIAL REGISTRATION:Clinicaltrials.gov: NCT00061828 and NCT00294684.

Dataset Information

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Publications

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets